project id: TCGA-ACC; case submitter id: TCGA-OR-A5KV; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.91; rna integrity number: 9.4; age at index: 17; days to birth: -6250; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1986; age at diagnosis: 6250; ajcc clinical m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage III; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3878.0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2003; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3429; initial weight: 50.0; sample id: 76f9abf7-01ab-48be-a7bb-23adddbcacf8; sample submitter id: TCGA-OR-A5KV-01A; portion id: bcab8e0e-bad6-4ecb-8e0f-76d1714f33b9; portion submitter id: TCGA-OR-A5KV-01A-11; slide id: 60bee376-1fa3-4200-b37d-ccfa4a61a9a7; slide submitter id: TCGA-OR-A5KV-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 4.0; percent tumor cells: 96.0; percent tumor nuclei: 100.0; section location: TOP;